The Pain, Depression, and Fatigue Symptom Cluster in Advanced Breast Cancer: Covariation with the Hypothalamic-pituitary-adrenal Axis and the Sympathetic Nervous System

Overview

Journal Health Psychol

Specialty Public Health

Date 2010 May 26

PMID 20496988

Citations 86

Authors

Lisa M Thornton

Barbara L Andersen

Wendy P Blakely

Affiliations

Soon will be listed here.

Abstract

Objective: Neuroendocrine-immune models have been proposed to account for the frequent co-occurrence of pain, depression, and fatigue (PDF) among cancer patients.

Design: In a cross-sectional observational study of advanced cancer patients (N = 104), we tested the hypothesis that the PDF cluster covaries with proposed biological mediators: hormones of the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenal (HPA) axis.

Main Outcome Measures: PDF symptoms were measured using the Brief Pain Inventory, Fatigue Symptom Inventory, and the Center for Epidemiological Studies Depression scales. HPA activation was indicated by plasma levels of cortisol and adrenocorticotropic hormone, and SNS activation was indicated by plasma epinephrine and norepinephrine.

Results: Preliminary analyses supported the use of covariance structure modeling to test whether shared variance among hormone levels predicted shared variance among PDF symptoms. Latent variable analysis indicated that neuroendocrine levels predicted PDF (standardized beta = .23, p = .039), while controlling for important disease and demographic variables.

Conclusion: Previous studies have linked individual symptoms to individual biomarkers. The observed significant paring of the 4 hormones to the PDF cluster provides the first evidence suggestive of stress hormones as a common mechanism for the co-occurrence of pain, depression, and fatigue symptoms.

Citing Articles

Effects of surgical trauma and intraoperative blood loss on tumour progression.

Jin X, Han H, Liang Q Front Oncol. 2024; 14:1412367.

PMID: 38912060 PMC: 11190163. DOI: 10.3389/fonc.2024.1412367.

Role of transforming growth factor-β1 pathway in angiogenesis induced by chronic stress in colorectal cancer.

Zhang J, Deng Y, Liu J, Gan L, Jiang Y Cancer Biol Ther. 2024; 25(1):2366451.

PMID: 38857055 PMC: 11168221. DOI: 10.1080/15384047.2024.2366451.

The role of lidocaine in cancer progression and patient survival.

Chida K, Kanazawa H, Kinoshita H, Roy A, Hakamada K, Takabe K Pharmacol Ther. 2024; 259:108654.

PMID: 38701900 PMC: 11162934. DOI: 10.1016/j.pharmthera.2024.108654.

Effects of Reishimmune-S, a Fungal Immunomodulatory Peptide Supplement, on the Quality of Life and Circulating Natural Killer Cell Profiles of Patients With Early Breast Cancer Receiving Adjuvant Endocrine Therapy.

Su Y, Huang W, Lin S, Yang P Integr Cancer Ther. 2024; 23:15347354241242120.

PMID: 38590244 PMC: 11005485. DOI: 10.1177/15347354241242120.

Exploring Inflammation and Stress as Biological Correlates of Symptoms in Children With Advanced Cancer: A Longitudinal Feasibility Study.

Montgomery K, Basha M, Nyholm L, Smith C, Ananiev G, Fedorov A J Pediatr Hematol Oncol Nurs. 2024; 41(3):157-171.

PMID: 38588659 PMC: 11874514. DOI: 10.1177/27527530231214544.

References

Ciaramella A, Poli P . Assessment of depression among cancer patients: the role of pain, cancer type and treatment. Psychooncology. 2001; 10(2):156-65. DOI: 10.1002/pon.505. View

Kirschbaum C, Kudielka B, Gaab J, Schommer N, Hellhammer D . Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom Med. 1999; 61(2):154-62. DOI: 10.1097/00006842-199903000-00006. View

Thornton L, Andersen B, Schuler T, Carson 3rd W . A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: secondary analysis of a randomized controlled trial. Psychosom Med. 2009; 71(7):715-24. PMC: 3832294. DOI: 10.1097/PSY.0b013e3181b0545c. View

van den Beuken-van Everdingen M, de Rijke J, Kessels A, Schouten H, van Kleef M, Patijn J . Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007; 18(9):1437-49. DOI: 10.1093/annonc/mdm056. View

Prue G, Rankin J, Allen J, Gracey J, Cramp F . Cancer-related fatigue: A critical appraisal. Eur J Cancer. 2006; 42(7):846-63. DOI: 10.1016/j.ejca.2005.11.026. View

Andersen B, Shapiro C, Farrar W, Crespin T, Wells-DiGregorio S . Psychological responses to cancer recurrence. Cancer. 2005; 104(7):1540-7. PMC: 2151214. DOI: 10.1002/cncr.21309. View

Vierck Jr C . Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia). Pain. 2006; 124(3):242-263. DOI: 10.1016/j.pain.2006.06.001. View

Cleeland C, Ryan K . Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994; 23(2):129-38. View

Brothers B, Andersen B . Hopelessness as a predictor of depressive symptoms for breast cancer patients coping with recurrence. Psychooncology. 2008; 18(3):267-75. PMC: 2743157. DOI: 10.1002/pon.1394. View

10.

Dantzer R, OConnor J, Freund G, Johnson R, Kelley K . From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2007; 9(1):46-56. PMC: 2919277. DOI: 10.1038/nrn2297. View

11.

Munkres A, Oberst M, Hughes S . Appraisal of illness, symptom distress, self-care burden, and mood states in patients receiving chemotherapy for initial and recurrent cancer. Oncol Nurs Forum. 1992; 19(8):1201-9. View

12.

Yang H, Thornton L, Shapiro C, Andersen B . Surviving recurrence: psychological and quality-of-life recovery. Cancer. 2008; 112(5):1178-87. PMC: 2435301. DOI: 10.1002/cncr.23272. View

13.

Segerstrom S, Miller G . Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004; 130(4):601-30. PMC: 1361287. DOI: 10.1037/0033-2909.130.4.601. View

14.

Hann D, Jacobsen P, Azzarello L, Martin S, Curran S, Fields K . Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res. 1998; 7(4):301-10. DOI: 10.1023/a:1024929829627. View

15.

Cleeland C, Bennett G, Dantzer R, Dougherty P, Dunn A, Meyers C . Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer. 2003; 97(11):2919-25. DOI: 10.1002/cncr.11382. View

16.

Dodd M, Miaskowski C, Lee K . Occurrence of symptom clusters. J Natl Cancer Inst Monogr. 2004; (32):76-8. DOI: 10.1093/jncimonographs/lgh008. View

17.

Howren M, Lamkin D, Suls J . Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009; 71(2):171-86. DOI: 10.1097/PSY.0b013e3181907c1b. View

18.

Lechin F, van der Dijs B, Benaim M . Stress versus depression. Prog Neuropsychopharmacol Biol Psychiatry. 1996; 20(6):899-950. DOI: 10.1016/0278-5846(96)00075-9. View

19.

Janssen S, Arntz A, Bouts S . Anxiety and pain: epinephrine-induced hyperalgesia and attentional influences. Pain. 1998; 76(3):309-316. DOI: 10.1016/S0304-3959(98)00060-8. View

20.

Barsevick A, Whitmer K, Nail L, Beck S, Dudley W . Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage. 2006; 31(1):85-95. DOI: 10.1016/j.jpainsymman.2005.05.015. View